Published in Proc Natl Acad Sci U S A on July 16, 2012
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency (AATD_Epi) | NCT02691611
Regulation of type I interferon responses. Nat Rev Immunol (2014) 3.60
New and emerging HDAC inhibitors for cancer treatment. J Clin Invest (2014) 3.35
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature (2015) 1.76
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature (2013) 1.59
Epigenetic regulation of macrophage polarization and function. Trends Immunol (2012) 1.50
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol (2017) 1.43
Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol (2014) 1.18
Histone deacetylases as targets for treatment of multiple diseases. Clin Sci (Lond) (2013) 1.16
Intermittent or sustained systemic inflammation and the preterm brain. Pediatr Res (2013) 1.08
Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog (2015) 1.05
Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol Metab (2012) 0.98
HDAC inhibitors and immunotherapy; a double edged sword? Oncotarget (2014) 0.97
Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Inflammopharmacology (2013) 0.95
The role of myeloid cells in cancer therapies. Nat Rev Cancer (2016) 0.92
The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer. Front Oncol (2014) 0.92
Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog (2015) 0.91
Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb Vasc Biol (2014) 0.90
Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly. PLoS One (2013) 0.89
Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages. J Biol Chem (2013) 0.89
FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. J Clin Invest (2015) 0.89
Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression. Ann Rheum Dis (2014) 0.87
Valproic acid attenuates lipopolysaccharide-induced acute lung injury in mice. Inflammation (2013) 0.87
The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J Exp Med (2016) 0.87
Modulation of TNF-induced macrophage polarization by synovial fibroblasts. J Immunol (2014) 0.86
Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation. Curr Opin Chem Biol (2016) 0.85
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med (2014) 0.84
Towards an understanding of cell-specific functions of signal-dependent transcription factors. J Mol Endocrinol (2013) 0.83
Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype. Mol Biol Cell (2015) 0.82
Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy. Antioxid Redox Signal (2014) 0.82
The ascent of acetylation in the epigenetics of rheumatoid arthritis. Nat Rev Rheumatol (2013) 0.81
HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol (2016) 0.81
Sepsis induces specific changes in histone modification patterns in human monocytes. PLoS One (2015) 0.81
Deciphering cis-regulatory control in inflammatory cells. Philos Trans R Soc Lond B Biol Sci (2013) 0.81
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors. Pharmaceuticals (Basel) (2014) 0.80
Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis (2016) 0.80
Epigenomic regulation of host-microbiota interactions. Trends Immunol (2014) 0.80
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Ann Clin Transl Neurol (2014) 0.80
Small-molecule control of cytokine function: new opportunities for treating immune disorders. Curr Opin Chem Biol (2014) 0.79
Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity. PLoS One (2015) 0.78
Epigenomics and the microbiota. Toxicol Pathol (2014) 0.78
Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation. Mediators Inflamm (2016) 0.78
Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block. J Autoimmun (2015) 0.78
Epigenetic Regulation of Myeloid Cells. Microbiol Spectr (2016) 0.77
Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis. PLoS Negl Trop Dis (2017) 0.77
Histone deacetylase 5 regulates the inflammatory response of macrophages. J Cell Mol Med (2015) 0.77
Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation. Proc Natl Acad Sci U S A (2016) 0.76
Anti-Inflammatory Effects of Spirulina platensis Extract via the Modulation of Histone Deacetylases. Nutrients (2016) 0.76
A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors. Int J Mol Sci (2017) 0.75
Anti-Inflammatory Effect of Spirulina platensis in Macrophages Is Beneficial for Adipocyte Differentiation and Maturation by Inhibiting Nuclear Factor-κB Pathway in 3T3-L1 Adipocytes. J Med Food (2016) 0.75
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases. Clin Transl Immunology (2016) 0.75
Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNS. Front Immunol (2016) 0.75
Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs? PLoS Pathog (2016) 0.75
The Hyaluronic Acid-HDAC3-miRNA Network in Allergic Inflammation. Front Immunol (2015) 0.75
The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice. PLoS One (2016) 0.75
Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes. Clin Epigenetics (2016) 0.75
HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Sci Rep (2017) 0.75
Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia. Neural Plast (2017) 0.75
Histone Deacetylases and Cardiometabolic Diseases. Arterioscler Thromb Vasc Biol (2015) 0.75
The therapeutic potential of epigenetic manipulation during infectious diseases. Pharmacol Ther (2016) 0.75
Epigenetic Regulation of Monocyte and Macrophage Function. Antioxid Redox Signal (2016) 0.75
HDAC3 inhibition ameliorates spinal cord injury by immunomodulation. Sci Rep (2017) 0.75
Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages. Cell Rep (2017) 0.75
Macrophages as Effectors of Acute and Chronic Allograft Injury. Curr Transplant Rep (2016) 0.75
Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget (2017) 0.75
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell (2010) 23.97
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol (2009) 11.63
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53
A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer (2006) 10.73
Structure and ligand of a histone acetyltransferase bromodomain. Nature (1999) 10.08
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet (2005) 8.99
Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
Cyclooxygenase in biology and disease. FASEB J (1998) 7.17
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol (2008) 6.90
IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity (2002) 6.85
Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 6.57
Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity (2010) 6.48
Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 6.34
A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell (2009) 6.26
The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell (2007) 6.07
Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (2009) 6.07
The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem (2009) 5.80
Prostaglandin E receptors. J Biol Chem (2007) 5.29
Transcriptional control of the inflammatory response. Nat Rev Immunol (2009) 5.20
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol (2011) 4.83
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell (2004) 4.39
15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A (2000) 3.89
Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet (2010) 3.29
A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science (2011) 3.00
Requirement of Hos2 histone deacetylase for gene activity in yeast. Science (2002) 2.95
The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A (2000) 2.92
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci U S A (2002) 2.91
The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev (2001) 2.76
Selective transcription in response to an inflammatory stimulus. Cell (2010) 2.75
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J (2009) 2.72
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell (2008) 2.71
Dimethylation of H3K4 by Set1 recruits the Set3 histone deacetylase complex to 5' transcribed regions. Cell (2009) 2.62
A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc Natl Acad Sci U S A (2004) 2.56
Histone deacetylases as regulators of inflammation and immunity. Trends Immunol (2011) 2.18
Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today (2005) 1.80
Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol (2010) 1.77
Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J (2004) 1.74
Isoform-selective histone deacetylase inhibitors. Chem Soc Rev (2008) 1.72
Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr Protoc Immunol (2011) 1.69
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev (2011) 1.54
Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis (2011) 1.51
The genomic landscapes of inflammation. Genes Dev (2011) 1.45
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol (2010) 1.44
Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol (2010) 1.40
c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol Cell Biol (2008) 1.20
The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50. Sci Signal (2011) 1.18
A feed-forward circuit controlling inducible NF-κB target gene activation by promoter histone demethylation. Mol Cell (2010) 1.16
Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. J Immunol (2008) 1.15
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate. Blood (2010) 1.12
Fish the ChIPs: a pipeline for automated genomic annotation of ChIP-Seq data. Biol Direct (2011) 0.84
Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor. Mol Endocrinol (2008) 0.83
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J (2003) 9.55
Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity (2010) 6.48
Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 6.34
The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell (2007) 6.07
A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol (2010) 6.01
p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol (2001) 4.38
Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell (2012) 4.10
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A (2010) 3.60
Latent enhancers activated by stimulation in differentiated cells. Cell (2013) 3.44
Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol (2002) 3.07
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A (2009) 3.01
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J (2009) 2.72
Modulation of NF-kappaB activity by exchange of dimers. Mol Cell (2003) 2.62
Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med (2004) 2.50
Noncooperative interactions between transcription factors and clustered DNA binding sites enable graded transcriptional responses to environmental inputs. Mol Cell (2010) 2.43
A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J (2006) 2.41
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Inhibition of spleen tyrosine kinase as treatment of postoperative ileus. Gut (2012) 2.20
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol (2009) 2.11
Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev (2002) 2.10
The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. Genes Dev (2006) 1.95
Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. EMBO J (2006) 1.94
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J Clin Invest (2011) 1.92
Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J (2012) 1.86
Mechanism of polymerase II transcription repression by the histone variant macroH2A. Mol Cell Biol (2006) 1.75
Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J (2004) 1.74
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol (2012) 1.67
Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity (2013) 1.64
Novel anti-inflammatory--pro-resolving mediators and their receptors. Curr Top Med Chem (2011) 1.61
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 1.60
ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res (2009) 1.60
The histone methyltransferase Wbp7 controls macrophage function through GPI glycolipid anchor synthesis. Immunity (2012) 1.60
The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One (2008) 1.57
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem (2009) 1.50
Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription. Cell (2009) 1.48
A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J Biol Chem (2004) 1.46
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev (2005) 1.45
The genomic landscapes of inflammation. Genes Dev (2011) 1.45
Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol (2009) 1.39
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol (2012) 1.37
Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol (2012) 1.31
Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology (2007) 1.29
Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochim Biophys Acta (2012) 1.27
Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol (2009) 1.25
FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J (2010) 1.23
Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J (2007) 1.22
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood (2013) 1.19
Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells. Nucleic Acids Res (2011) 1.16
The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J Exp Med (2007) 1.16
Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples. Proc Natl Acad Sci U S A (2010) 1.15
Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue. Nat Protoc (2011) 1.15
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol (2006) 1.14
Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci Rep (2012) 1.09
The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. J Exp Med (2009) 1.08
Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. Proc Natl Acad Sci U S A (2012) 1.08
Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. J Med Genet (2012) 1.07
Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J Immunol (2013) 1.06
HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev (2014) 1.03
The H3K27 demethylase JMJD3 is required for maintenance of the embryonic respiratory neuronal network, neonatal breathing, and survival. Cell Rep (2012) 1.01
New therapeutic strategies for postoperative ileus. Nat Rev Gastroenterol Hepatol (2012) 1.01
Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol (2011) 1.00
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity. FASEB J (2011) 1.00
Short-term memory of danger signals and environmental stimuli in immune cells. Nat Immunol (2013) 0.99
The transcriptional repressor NKAP is required for the development of iNKT cells. Nat Commun (2013) 0.99
Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol (2008) 0.99
Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood (2010) 0.97
The signaling adaptor Eps8 is an essential actin capping protein for dendritic cell migration. Immunity (2011) 0.96
Chromatin contributions to the regulation of innate immunity. Annu Rev Immunol (2014) 0.95
Charting the NF-κB pathway interactome map. PLoS One (2012) 0.94
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J (2010) 0.93
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. Prostaglandins Leukot Essent Fatty Acids (2009) 0.93
Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophils. J Immunol (2013) 0.93
Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm Bowel Dis (2008) 0.92
Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. J Nat Prod (2014) 0.92
Seasonal environmental changes regulate the expression of the histone variant macroH2A in an eurythermal fish. FEBS Lett (2005) 0.91
Identification of clinical outcome measures for recovery of gastrointestinal motility in postoperative ileus. Ann Surg (2014) 0.90
Microparticles are novel effectors of immunity. Curr Opin Pharmacol (2013) 0.88
Transcriptional control of macrophage diversity and specialization. Eur J Immunol (2011) 0.88
Tgif1 regulates quiescence and self-renewal of hematopoietic stem cells. Mol Cell Biol (2013) 0.87
Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity. J Exp Med (2008) 0.86
Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators. Crit Care Med (2016) 0.86
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood (2008) 0.85
Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression. Circ Res (2013) 0.85
Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation. Eur J Immunol (2011) 0.85